EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy?

Muhammad Sameed, Zhou Meng, Ellen T. Marciniak

Source: Breathe, 15 (3) 244; 10.1183/20734735.0363-2018
Journal Issue: September
Disease area: Respiratory critical care

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Muhammad Sameed, Zhou Meng, Ellen T. Marciniak. EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy?. Breathe, 15 (3) 244; 10.1183/20734735.0363-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation support: a consequence of vaping
Source: ERJ Open Res, 6 (2) 00013-2020; 10.1183/23120541.00013-2020
Year: 2020



Extracorporeal membrane oxygenation in a nonintubated patient with acute respiratory distress syndrome
Source: Eur Respir J 2012; 40: 1296-1298
Year: 2012


Impact of experience and education in treatment of adult respiratory distress syndrome (ARDS) using extracorporeal membrane oxygenation (ECMO)
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012


Early corticosteroid in influenza pneumonia related acute respiratory distress syndrome treated with extracorporeal membrane oxygenation
Source: International Congress 2018 – Preclinical and clinical studies of critical illness
Year: 2018

Extracorporeal support for patients with acute respiratory distress syndrome
Source: Eur Respir Rev 2014; 23: 379-389
Year: 2014



Thirty months’ experience with bicaval dual lumen cannula for venovenous extracorporeal membrane oxygenation in refractory acute respiratory distress syndrome
Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Year: 2013


Prone position in acute respiratory distress syndrome
Source: Eur Respir J 2002; 20: 1017-1028
Year: 2002



Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy
Source: Eur Respir J 2009; 33: 551-558
Year: 2009



Extracorporeal membrane oxygenation for acute respiratory distress syndrome due to Pneumocystis pneumonia
Source: Eur Respir J, 54 (3) 1900410; 10.1183/13993003.00410-2019
Year: 2019



Extracorporeal CO2 removal for refractory hypercapnia in acute respiratory failure: A case series
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016


Implications of multidisciplinary team setups for venovenous extracorporeal membrane oxygenation in acute respiratory failure
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019


Current invasive ventilatory strategies in acute respiratory distress syndrome
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=161
Year: 2002

Surfactant therapy in acute lung injury/acute respiratory distress syndrome
Source: Eur Respir Mon 2012; 55: 54-64
Year: 2012


Extracorporeal membrane oxygenation
Source: Eur Respir Mon 2012; 55: 133-141
Year: 2012


Evaluation of lung-protective ventilation strategies in acute respiratory distress syndrome
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=195
Year: 2002

Combined cell therapy and anticoagulants for acute respiratory distress syndrome
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020


A survey on the use in clinical practice of noninvasive positive pressure ventilation (NPPV) as a first-line intervention for acute respiratory distress syndrome (ARDS)
Source: Annual Congress 2013 –NIV in the acute setting: growing experience and novel applications
Year: 2013


Early intervention with non-invasive respiratory therapies in mild acute respiratory distress syndrome secondary to COVID-19
Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19
Year: 2021


Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome
Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management
Year: 2006


Prone positioning in patients with COVID-19 under invasive mechanical ventilation and acute respiratory distress syndrome: a multicenter cohort study
Source: Virtual Congress 2021 – COVID-19 acute respiratory distress syndrome
Year: 2021